Subsequent Events	3 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 8 – SUBSEQUENT EVENTS The company’s management has evaluated subsequent events occurring after March 31, 2024, the date of our most recent balance sheet, through the date our financial statements were issued. Subsequent to the year period ended March 31, 2024, the company issued 10,000 shares of common stock upon the exercise of options at an exercise price of $0.07 per share. The company received $700 in cash proceeds, minus required withholding, from the exercise of such options. Subsequent to the year period ended March 31, 2024, the company issued 10,000 shares of common stock upon the exercise of options at an exercise price of $0.35 per share. The company received $3,500 in cash proceeds, minus required withholding, from the exercise of such options. Subsequent to the year period ended March 31, 2024, the company issued 16,500 shares of common stock upon exercise of warrants at an exercise price of $0.06 per share. The company received $990 in proceeds from the exercise of such options. On May 10, 2024, the company completed the placement of 1,896,182 shares of its common stock, par value, $0.001 per share, in a private sale to individual purchasers at a price of $2.20 per share, for aggregate proceeds in the amount of $4,171,600. All of the purchasers are accredited, sophisticated investors, and the issuance of the shares was not in connection with any public offering in accordance with Section 4(a)(2) of the Securities Act of 1933.

Subsequent Events

3 Months Ended

Mar. 31, 2024

NOTE 8 – SUBSEQUENT EVENTS

The company’s management has evaluated subsequent events occurring after March 31, 2024, the date of our most recent balance sheet, through the date our financial statements were issued.

Subsequent to the year period ended March 31, 2024, the company issued 10,000 shares of common stock upon the exercise of options at an exercise price of $0.07 per share. The company received $700 in cash proceeds, minus required withholding, from the exercise of such options.

Subsequent to the year period ended March 31, 2024, the company issued 10,000 shares of common stock upon the exercise of options at an exercise price of $0.35 per share. The company received $3,500 in cash proceeds, minus required withholding, from the exercise of such options.

Subsequent to the year period ended March 31, 2024, the company issued 16,500 shares of common stock upon exercise of warrants at an exercise price of $0.06 per share. The company received $990 in proceeds from the exercise of such options.

On May 10, 2024, the company completed the placement of 1,896,182 shares of its common stock, par value, $0.001 per share, in a private sale to individual purchasers at a price of $2.20 per share, for aggregate proceeds in the amount of $4,171,600. All of the purchasers are accredited, sophisticated investors, and the issuance of the shares was not in connection with any public offering in accordance with Section 4(a)(2) of the Securities Act of 1933.